1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Targeting TUBG1 in RB1-negative tumors
(2025) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39(5).
- Contribution to journal › Article
-
Mark
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma
- Contribution to journal › Article
- 2019
-
Mark
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
- Contribution to journal › Article
-
Mark
ABCC3 is a novel target for the treatment of pancreatic cancer
- Contribution to journal › Article
-
Mark
Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells
- Contribution to journal › Article
- 2018
-
Mark
Acetonic extracts of the endolichenic fungus EL002332 isolated from Endocarpon pusillum exhibits anticancer activity in human gastric cancer cells
- Contribution to journal › Article
- 2015
-
Mark
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
- Contribution to journal › Article
- 2014
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
(2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842
- Contribution to journal › Article
-
Mark
Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway
- Contribution to journal › Article
- 2012
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
- Contribution to journal › Article
